11/10
05:06 pm
prok
ProKidney GAAP EPS of -$0.12 beats by $0.02, revenue of $0.22M beats by $0.18M [Seeking Alpha]
Low
Report
ProKidney GAAP EPS of -$0.12 beats by $0.02, revenue of $0.22M beats by $0.18M [Seeking Alpha]
11/10
04:41 pm
prok
ProKidney Reports Third Quarter 2025 Financial Results and Provides Regulatory and Clinical Updates [Yahoo! Finance]
Low
Report
ProKidney Reports Third Quarter 2025 Financial Results and Provides Regulatory and Clinical Updates [Yahoo! Finance]
11/10
04:15 pm
prok
ProKidney Reports Third Quarter 2025 Financial Results and Provides Regulatory and Clinical Updates
Low
Report
ProKidney Reports Third Quarter 2025 Financial Results and Provides Regulatory and Clinical Updates
11/6
11:00 am
prok
ProKidney Presents Full Results from the Phase 2 REGEN-007 Trial of Rilparencel at the American Society of Nephrology Kidney Week 2025
Medium
Report
ProKidney Presents Full Results from the Phase 2 REGEN-007 Trial of Rilparencel at the American Society of Nephrology Kidney Week 2025
10/29
07:30 am
prok
ProKidney to Participate in Two Upcoming Conferences: Guggenheim Healthcare Innovation Conference and the Jefferies Global Healthcare Conference
Low
Report
ProKidney to Participate in Two Upcoming Conferences: Guggenheim Healthcare Innovation Conference and the Jefferies Global Healthcare Conference
10/20
07:30 am
prok
ProKidney Announces Two Abstracts Selected for Presentation at the American Society of Nephrology’s Kidney Week 2025
High
Report
ProKidney Announces Two Abstracts Selected for Presentation at the American Society of Nephrology’s Kidney Week 2025
9/20
03:08 am
prok
ProKidney Corp (PROK) Touts Reparencel Therapy for Growth [Yahoo! Finance]
Medium
Report
ProKidney Corp (PROK) Touts Reparencel Therapy for Growth [Yahoo! Finance]
9/19
10:54 am
prok
ProKidney: Slow-Burning 'Buy' Opportunity Based On 2027 Approval Of Kidney Disease Therapy [Seeking Alpha]
Low
Report
ProKidney: Slow-Burning 'Buy' Opportunity Based On 2027 Approval Of Kidney Disease Therapy [Seeking Alpha]
9/12
08:34 am
prok
ProKidney Leads Our Trio Of Promising Penny Stocks [Yahoo! Finance]
High
Report
ProKidney Leads Our Trio Of Promising Penny Stocks [Yahoo! Finance]